Actemra | tocilizumab
Drug Class: Immunosuppressive, interleukin-6 (IL-6) blocker
Approval date: January, 2010
What is Actemra and how does it work
Actemra is a man-made protein that blocks the effects of interleukin-6 (IL-6) in patients with rheumatoid arthritis (RA). It is a biologic disease modifying antirheumatic drug (DMARD).
What does Actemra treat
How well does Actemra work for RA
What are interesting facts about Actemra
How is Actemra dosed (dosage) and administered
Adults: 4-8 mg/kg of Actemra is infused intravenously over 1 hour every 4 weeks
Children: 8-12 mg/kg every 2 weeks
What are the side effects of Actemra
Common: Respiratory tract infections, headaches, high blood pressure, redness, swelling, itching.
Serious: Nervous system disorders, cancer, tuberculosis, bacteria in the blood, fungal infections, reactivation of herpes zoster, decrease in white blood cells and platelets, and allergic reactions.
Actemra Drug interactions
How to obtain prescription assistance for Actemra
For Actemra prescription assistance visit Actemra patient assistance program.
References: Actemra FDA Prescribing Information
The material on this site is for information only and is not a substitute for medical advice, diagnosis or treatment provided by a qualified healthcare provider.
Comment on this article or post an article by joining the RxEconsult community.
Please Share on Your Social Networks